Profile data is unavailable for this security.
About the company
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
- Revenue in USD (TTM)276.54bn
- Net income in USD1.85bn
- Incorporated2001
- Employees42.00k
- LocationCencora Inc1 West First AvenueCONSHOHOCKEN 19428United StatesUSA
- Phone+1 (610) 727-7000
- Fax+1 (302) 655-5049
- Websitehttps://www.cencora.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steris PLC | 5.14bn | 551.44m | 22.61bn | 18.18k | 41.14 | 3.59 | 20.21 | 4.40 | 5.56 | 3.81 | 51.79 | 63.73 | 0.4696 | 4.26 | 5.31 | 282,672.40 | 5.06 | 5.19 | 5.51 | 5.68 | 43.17 | 43.64 | 10.77 | 10.97 | 2.36 | 6.75 | 0.3367 | 36.56 | 13.28 | 13.06 | -1.07 | 12.67 | 13.69 | 8.83 |
| Zimmer Biomet Holdings Inc | 7.45bn | 963.80m | 22.85bn | 18.00k | 24.04 | 1.81 | 11.88 | 3.07 | 4.62 | 4.62 | 35.72 | 61.24 | 0.3491 | 0.9052 | 5.27 | 414,027.80 | 4.52 | 2.21 | 5.14 | 2.52 | 71.89 | 71.25 | 12.95 | 7.28 | 0.802 | 7.32 | 0.315 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 23.82bn | 10.60k | 43.12 | 8.91 | 34.34 | 8.13 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Veeva Systems Inc | 2.49bn | 555.85m | 29.41bn | 7.17k | 52.00 | 6.01 | 49.89 | 11.82 | 3.50 | 3.50 | 14.80 | 30.25 | 0.4438 | -- | 5.84 | 346,861.80 | 9.92 | 11.97 | 12.38 | 15.36 | 72.48 | 72.00 | 22.34 | 23.74 | -- | -- | 0.00 | 0.00 | 9.68 | 22.35 | 7.79 | 18.00 | 21.68 | -- |
| Mettler-Toledo International Inc | 3.79bn | 777.86m | 29.44bn | 16.00k | 38.65 | -- | 32.71 | 7.78 | 35.66 | 35.66 | 173.66 | -7.43 | 1.13 | 3.85 | 5.87 | 236,595.00 | 23.24 | 23.32 | 34.14 | 34.02 | 59.25 | 58.58 | 20.55 | 20.51 | 0.7398 | 13.83 | 1.08 | 0.00 | -3.35 | 5.23 | -9.60 | 8.85 | -5.90 | -- |
| Resmed Inc | 4.58bn | 958.38m | 30.26bn | 10.14k | 31.70 | 6.53 | 26.58 | 6.60 | 6.50 | 6.50 | 31.07 | 31.52 | 0.6777 | 2.20 | 5.99 | 452,086.70 | 14.17 | 13.59 | 15.98 | 15.89 | 55.78 | 56.98 | 20.91 | 19.22 | 1.97 | 25.88 | 0.1786 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
| GE HealthCare Technologies Inc | 19.50bn | 1.57bn | 37.64bn | 51.00k | 24.01 | 5.08 | 16.93 | 1.93 | 3.43 | 3.43 | 42.54 | 16.24 | 0.6013 | 5.45 | 4.51 | 382,254.90 | 5.01 | -- | 6.86 | -- | 40.69 | -- | 8.33 | -- | 0.8335 | 5.27 | 0.5491 | -- | 6.60 | -- | -26.82 | -- | -- | -- |
| Agilent Technologies Inc | 6.59bn | 1.24bn | 38.95bn | 17.60k | 31.67 | 6.26 | 25.97 | 5.91 | 4.22 | 4.22 | 22.38 | 21.31 | 0.6089 | 3.09 | 4.97 | 364,143.70 | 11.47 | 11.00 | 13.78 | 13.25 | 50.63 | 53.29 | 18.84 | 18.01 | 1.64 | 124.23 | 0.2915 | 21.46 | -0.219 | 6.82 | -1.12 | 7.39 | 10.98 | 8.86 |
| IDEXX Laboratories, Inc. | 3.72bn | 866.57m | 41.00bn | 11.00k | 48.11 | 26.22 | 41.71 | 11.01 | 10.32 | 10.32 | 44.36 | 18.93 | 1.21 | 3.80 | 7.05 | 338,623.00 | 28.13 | 28.00 | 41.87 | 43.49 | 60.14 | 58.74 | 23.26 | 21.35 | 1.16 | 41.81 | 0.3761 | 0.00 | 8.72 | 10.59 | 24.44 | 17.39 | 1.68 | -- |
| Cencora Inc | 276.54bn | 1.85bn | 44.91bn | 42.00k | 24.63 | 41.45 | 15.11 | 0.1624 | 9.14 | 9.14 | 1,364.32 | 5.43 | 4.51 | 15.45 | 12.34 | 6,584,203.00 | 3.02 | 0.9542 | 13.51 | 3.95 | 3.40 | 3.14 | 0.6699 | 0.2178 | 0.5331 | 12.61 | 0.8105 | 76.85 | 9.89 | 9.32 | 2.74 | 10.79 | 6.38 | 5.00 |
| DexCom Inc | 3.80bn | 639.30m | 45.58bn | 9.60k | 75.54 | 20.21 | 54.51 | 11.99 | 1.52 | 1.52 | 8.99 | 5.67 | 0.6337 | 2.93 | 4.71 | 396,020.80 | 10.66 | 8.30 | 14.97 | 10.50 | 63.25 | 65.90 | 16.82 | 14.14 | 2.53 | -- | 0.526 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
| Edwards Lifesciences Corp | 6.14bn | 1.41bn | 52.61bn | 19.80k | 37.53 | 7.39 | 33.77 | 8.56 | 2.33 | 2.33 | 10.11 | 11.82 | 0.6682 | 1.35 | 8.00 | 310,272.70 | 15.34 | 16.63 | 17.58 | 19.12 | 76.63 | 76.71 | 22.95 | 24.84 | 2.67 | -- | 0.0767 | 0.00 | 11.56 | 10.03 | -7.85 | 13.70 | 1.96 | -- |
Data as of Jul 22 2024. Currency figures normalised to Cencora Inc's reporting currency: US Dollar USD
35.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 19.62m | 9.84% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 11.26m | 5.64% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 8.76m | 4.39% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 7.92m | 3.97% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 4.50m | 2.26% |
| JPMorgan Investment Management, Inc.as of 31 Mar 2024 | 4.26m | 2.14% |
| Boston Partners Global Investors, Inc.as of 31 Mar 2024 | 4.12m | 2.07% |
| Wellington Management Co. LLPas of 31 Mar 2024 | 4.07m | 2.04% |
| Geode Capital Management LLCas of 31 Mar 2024 | 3.92m | 1.97% |
| Capital Research & Management Co. (Global Investors)as of 31 Mar 2024 | 2.68m | 1.34% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
